{
    "Trade/Device Name(s)": [
        "Athelas Home"
    ],
    "Submitter Information": "Athelas Inc.",
    "510(k) Number": "K200828",
    "Predicate Device Reference 510(k) Number(s)": [
        "K181288"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "GKZ"
    ],
    "Summary Letter Date": "November 25, 2021",
    "Summary Letter Received Date": "November 29, 2021",
    "Submission Date": "January 17, 2021",
    "Regulation Number(s)": [
        "21 CFR 864.5220"
    ],
    "Regulation Name(s)": [
        "Automated Differential Cell Counter"
    ],
    "Analyte Class(es)": [
        "hematology"
    ],
    "Analyte(s)": [
        "White Blood Cells",
        "Neutrophil Percentages"
    ],
    "Specimen Type(s)": [
        "Capillary whole blood"
    ],
    "Specimen Container(s)": [
        "Athelas Home Test Strips"
    ],
    "Instrument(s)/Platform(s)": [
        "Athelas Home"
    ],
    "Method(s)/Technology(ies)": [
        "Microfluidics",
        "Image processing",
        "Computer vision-based image analysis"
    ],
    "Methodologies": [
        "Cell counting",
        "Differential analysis"
    ],
    "Submission Type(s)": [
        "Analyzer",
        "Test Strip",
        "Control"
    ],
    "Document Summary": "FDA 510(k) summary for Athelas Home automated differential cell counter for measuring WBC and neutrophil percentages from capillary whole blood in home settings",
    "Indications for Use Summary": "Quantitative determination of white blood cells and neutrophil percentages in capillary whole blood for adult patients at risk of neutropenia, for prescription in-home use with results viewable by healthcare professionals",
    "fda_folder": "Hematology"
}